Financials
- Market Capitalization 274.51 M
- Employee 43
- Founded 2015
- CEO N/A
- Website www.alxoncology.com
- Headquarter Delaware, United States
- FIGI BBG00VR8SDG8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3405 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.62 USD | +0.56% | -3.98% | -7.18% | +29.29% | 276.80 M USD | ||
| 3411 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | 0.00% | +23.95% | +15.00% | 273.31 M USD | ||
| 3422 | MGNX MacroGenics, Inc. - Common Stock | 4.33 USD | +0.93% | -7.08% | +4.34% | +188.67% | 275.23 M USD | ||
| 3427 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.11 USD | +4.56% | -2.87% | +8.88% | +2.01% | 276.01 M USD |